{"transactions":[{"id":3211304,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":150656,"kind":"person","name":"AYCARDI-FONSECA ERNESTO","position":1,"cik":"0001734218","reported_name":"AYCARDI-FONSECA ERNESTO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-13T17:06:38.000Z","date":"2020-03-12","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on January 1, 2021 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":65000,"derivative":{"exercise_price":11.58,"expiration_date":"2030-03-11","underlying":"Common Shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-20-018958","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734218/000120919120018958/doc4.xml","form_type":"4"}},{"id":3410998,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":150656,"kind":"person","name":"AYCARDI-FONSECA ERNESTO","position":1,"cik":"0001734218","reported_name":"AYCARDI-FONSECA ERNESTO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-18T18:21:26.000Z","date":"2019-09-16","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting over 36 months, in equal amounts, on the last day of each month."}],"balance_after":65000,"derivative":{"exercise_price":9.44,"expiration_date":"2029-09-15","underlying":"Common Shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-19-050127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734218/000120919119050127/doc4.xml","form_type":"4"}},{"id":3987770,"issuer":{"id":2602,"kind":"organization","name":"Xenon Pharmaceuticals Inc.","symbol":"XENE"},"owners":[{"id":150656,"kind":"person","name":"AYCARDI-FONSECA ERNESTO","position":1,"cik":"0001734218","reported_name":"AYCARDI-FONSECA ERNESTO","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-20T16:44:24.000Z","date":"2018-03-19","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Vesting 25% on March 19, 2019, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month."}],"balance_after":50000,"derivative":{"exercise_price":4.65,"expiration_date":"2028-03-18","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001171843-18-002118","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734218/000117184318002118/formfour.xml","form_type":"4"}}]}